Clinical Trial Update: A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria [Phase 2]

View source ↗

Summary

Phase 2 study of LY3454738 in adults with chronic spontaneous urticaria was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• LY3454738 (LY3454738)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Chronic Spontaneous Urticaria | Phase 2 | Status: TERMINATED | Results posted: 2022-03-11